Treatment with CPD-Lipo resulted in minimal BxPC-3 cell death, indicating low cytotoxicity and supporting its biosafety profile in vitro
Risks include: Unknown ingredients that may interact with other medications or health conditions Lack of sterility, which can lead to infections Product that does not contain any active medication Taking GLP-1s can have side effects some moderate and some more serious, such as severe vomiting and diarrhea, severe constipation, gallstones, and pancreatitis
Each study was classified as having a high, unclear, or low risk of bias in these areas
Think: gentle exfoliation (like AHAs or BHAs), proper cleansing, oil control, and daily SPF
Provincial Reimbursement Varies Federal approval does not automatically translate into provincial drug plan coverage